US Stock MarketDetailed Quotes

KTRA Kintara Therapeutics

Watchlist
  • 0.2160
  • +0.0370+20.67%
Close Jun 18 16:00 ET
  • 0.2076
  • -0.0084-3.89%
Pre 04:57 ET
11.95MMarket Cap-93P/E (TTM)

Kintara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
(Q1)Sep 30, 2022
(FY)Jun 30, 2022
(Q4)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-25.89%-2.3M
2.04%-2.12M
79.32%-1.32M
41.82%-11.87M
69.79%-1.51M
65.02%-1.83M
57.66%-2.16M
-25.55%-6.37M
-8.12%-20.39M
-6.46%-4.99M
Net income from continuing operations
38.39%-2.01M
70.38%-1.02M
35.55%-2.96M
35.36%-14.65M
38.76%-3.34M
39.06%-3.26M
41.39%-3.45M
22.96%-4.6M
40.83%-22.66M
19.10%-5.45M
Operating gains losses
----
----
----
471.43%200K
----
----
----
----
-93.85%35K
--0
Depreciation and amortization
-46.67%8K
0.00%15K
0.00%15K
0.00%60K
0.00%15K
0.00%15K
0.00%15K
0.00%15K
87.50%60K
0.00%15K
Other non cash items
-95.84%55K
-95.37%50K
155.17%48K
17,089.47%3.23M
10,244.44%913K
22,150.00%1.32M
108,000.00%1.08M
-2,800.00%-87K
-116.10%-19K
99.94%-9K
Change In working capital
-165.97%-508K
-458.65%-1.32M
164.08%1.42M
-3,889.09%-2.19M
-6.21%453K
63.13%-191K
-301.69%-237K
-5,789.74%-2.22M
97.93%-55K
-43.97%483K
-Change in prepaid assets
-91.86%21K
1,875.00%142K
167.13%1.17M
-8.76%-1.33M
171.88%161K
180.63%258K
98.80%-8K
-13,284.62%-1.74M
50.75%-1.22M
-298.23%-224K
-Change in payables and accrued expense
-17.82%-529K
-540.17%-1.47M
153.03%254K
-174.12%-865K
-58.70%292K
-126.77%-449K
-137.79%-229K
-1,021.15%-479K
786.47%1.17M
-5.61%707K
Cash from discontinued investing activities
Operating cash flow
-25.89%-2.3M
2.04%-2.12M
79.32%-1.32M
41.82%-11.87M
69.79%-1.51M
65.02%-1.83M
57.66%-2.16M
-25.55%-6.37M
-8.12%-20.39M
-6.46%-4.99M
Investing cash flow
Cash flow from continuing investing activities
0
-20K
0
-232K
0
0
0
-232K
0
0
Net PPE purchase and sale
--0
---20K
--0
---232K
--0
--0
--0
---232K
--0
--0
Cash from discontinued investing activities
Investing cash flow
--0
---20K
--0
---232K
--0
--0
--0
---232K
--0
--0
Financing cash flow
Cash flow from continuing financing activities
399,750.00%7.99M
5,258.00%2.58M
-100.10%-2K
-91.44%1.85M
-100.03%-2K
0.00%-2K
70.76%-50K
-86.26%1.91M
-16.92%21.64M
1,712.40%7.93M
Net common stock issuance
--8M
5,477.08%2.58M
--0
-91.18%1.9M
-99.46%43K
--0
71.60%-48K
-86.18%1.91M
-0.13%21.57M
--7.94M
Cash dividends paid
0.00%-2K
0.00%-2K
0.00%-2K
0.00%-8K
0.00%-2K
0.00%-2K
0.00%-2K
0.00%-2K
0.00%-8K
0.00%-2K
Proceeds from stock option exercised by employees
----
----
----
--0
----
----
----
----
-98.35%74K
--0
Net other financing activities
----
----
----
---43K
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
399,750.00%7.99M
5,258.00%2.58M
-100.10%-2K
-91.44%1.85M
-100.03%-2K
0.00%-2K
70.76%-50K
-86.26%1.91M
-16.92%21.64M
1,712.40%7.93M
Net cash flow
Beginning cash position
-86.50%658K
-96.95%216K
-86.97%1.54M
11.80%11.78M
-65.55%3.05M
-65.34%4.87M
-63.36%7.09M
11.80%11.78M
340.51%10.54M
-43.77%8.84M
Current changes in cash
411.26%5.69M
119.99%442K
71.91%-1.32M
-924.22%-10.25M
-151.34%-1.51M
65.00%-1.83M
58.09%-2.21M
-153.34%-4.7M
-84.74%1.24M
156.77%2.94M
End cash Position
108.57%6.35M
-86.50%658K
-96.95%216K
-86.97%1.54M
-86.97%1.54M
-65.55%3.05M
-65.34%4.87M
-63.36%7.09M
11.80%11.78M
11.80%11.78M
Free cash flow
-25.89%-2.3M
1.11%-2.14M
80.05%-1.32M
40.68%-12.1M
69.79%-1.51M
65.02%-1.83M
57.66%-2.16M
-30.12%-6.6M
-8.08%-20.39M
-6.46%-4.99M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022(Q1)Sep 30, 2022(FY)Jun 30, 2022(Q4)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -25.89%-2.3M2.04%-2.12M79.32%-1.32M41.82%-11.87M69.79%-1.51M65.02%-1.83M57.66%-2.16M-25.55%-6.37M-8.12%-20.39M-6.46%-4.99M
Net income from continuing operations 38.39%-2.01M70.38%-1.02M35.55%-2.96M35.36%-14.65M38.76%-3.34M39.06%-3.26M41.39%-3.45M22.96%-4.6M40.83%-22.66M19.10%-5.45M
Operating gains losses ------------471.43%200K-----------------93.85%35K--0
Depreciation and amortization -46.67%8K0.00%15K0.00%15K0.00%60K0.00%15K0.00%15K0.00%15K0.00%15K87.50%60K0.00%15K
Other non cash items -95.84%55K-95.37%50K155.17%48K17,089.47%3.23M10,244.44%913K22,150.00%1.32M108,000.00%1.08M-2,800.00%-87K-116.10%-19K99.94%-9K
Change In working capital -165.97%-508K-458.65%-1.32M164.08%1.42M-3,889.09%-2.19M-6.21%453K63.13%-191K-301.69%-237K-5,789.74%-2.22M97.93%-55K-43.97%483K
-Change in prepaid assets -91.86%21K1,875.00%142K167.13%1.17M-8.76%-1.33M171.88%161K180.63%258K98.80%-8K-13,284.62%-1.74M50.75%-1.22M-298.23%-224K
-Change in payables and accrued expense -17.82%-529K-540.17%-1.47M153.03%254K-174.12%-865K-58.70%292K-126.77%-449K-137.79%-229K-1,021.15%-479K786.47%1.17M-5.61%707K
Cash from discontinued investing activities
Operating cash flow -25.89%-2.3M2.04%-2.12M79.32%-1.32M41.82%-11.87M69.79%-1.51M65.02%-1.83M57.66%-2.16M-25.55%-6.37M-8.12%-20.39M-6.46%-4.99M
Investing cash flow
Cash flow from continuing investing activities 0-20K0-232K000-232K00
Net PPE purchase and sale --0---20K--0---232K--0--0--0---232K--0--0
Cash from discontinued investing activities
Investing cash flow --0---20K--0---232K--0--0--0---232K--0--0
Financing cash flow
Cash flow from continuing financing activities 399,750.00%7.99M5,258.00%2.58M-100.10%-2K-91.44%1.85M-100.03%-2K0.00%-2K70.76%-50K-86.26%1.91M-16.92%21.64M1,712.40%7.93M
Net common stock issuance --8M5,477.08%2.58M--0-91.18%1.9M-99.46%43K--071.60%-48K-86.18%1.91M-0.13%21.57M--7.94M
Cash dividends paid 0.00%-2K0.00%-2K0.00%-2K0.00%-8K0.00%-2K0.00%-2K0.00%-2K0.00%-2K0.00%-8K0.00%-2K
Proceeds from stock option exercised by employees --------------0-----------------98.35%74K--0
Net other financing activities ---------------43K------------------------
Cash from discontinued financing activities
Financing cash flow 399,750.00%7.99M5,258.00%2.58M-100.10%-2K-91.44%1.85M-100.03%-2K0.00%-2K70.76%-50K-86.26%1.91M-16.92%21.64M1,712.40%7.93M
Net cash flow
Beginning cash position -86.50%658K-96.95%216K-86.97%1.54M11.80%11.78M-65.55%3.05M-65.34%4.87M-63.36%7.09M11.80%11.78M340.51%10.54M-43.77%8.84M
Current changes in cash 411.26%5.69M119.99%442K71.91%-1.32M-924.22%-10.25M-151.34%-1.51M65.00%-1.83M58.09%-2.21M-153.34%-4.7M-84.74%1.24M156.77%2.94M
End cash Position 108.57%6.35M-86.50%658K-96.95%216K-86.97%1.54M-86.97%1.54M-65.55%3.05M-65.34%4.87M-63.36%7.09M11.80%11.78M11.80%11.78M
Free cash flow -25.89%-2.3M1.11%-2.14M80.05%-1.32M40.68%-12.1M69.79%-1.51M65.02%-1.83M57.66%-2.16M-30.12%-6.6M-8.08%-20.39M-6.46%-4.99M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-2.28%